Regent Investment Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-20,000	Closed	-$17K	–	191
2020 Q2	$17K	Hold	20,000	–	–	0.01%	185
2020 Q1	$17K	Hold	20,000	–	–	0.01%	178
2019 Q4	$18K	Hold	20,000	–	–	0.01%	208
2019 Q3	$20K	Hold	20,000	–	–	0.01%	204
2019 Q2	$22K	Hold	20,000	–	–	0.01%	205
2019 Q1	$26K	Hold	20,000	–	–	0.01%	206
2018 Q4	$18K	Sell	20,000 -5,718	-22%	-$8.76K	0.01%	195
2018 Q3	$53K	Hold	25,718	–	–	0.02%	203
2018 Q2	$46K	Hold	25,718	–	–	0.02%	199
2018 Q1	$61K	Hold	25,718	–	–	0.02%	204
2017 Q4	$48K	Hold	25,718	–	–	0.02%	205
2017 Q3	$64K	Hold	25,718	–	–	0.02%	207
2017 Q2	$71K	Buy	25,718 +11,430	+80%	+$31.9K	0.03%	207
2017 Q1	$43K	Hold	14,288	–	–	0.02%	199
2016 Q4	$45K	Buy	14,288 +2,858	+25%	+$8.78K	0.02%	181
2016 Q3	$39K	Buy	+11,430	New	+$31.6K	0.02%	181